Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.

Knight, Deborah A; Ngiow, Shin Foong; Li, Ming; Parmenter, Tiffany; Mok, Stephen; Cass, Ashley; Haynes, Nicole M; Kinross, Kathryn; Yagita, Hideo; Koya, Richard C; Graeber, Thomas G; Ribas, Antoni; McArthur, Grant A; Smyth, Mark J

Knight, Deborah A; Ngiow, Shin Foong; Li, Ming; Parmenter, Tiffany; Mok, Stephen; Cass, Ashley; Haynes, Nicole M; Kinross, Kathryn; Yagita, Hideo; Koya, Richard C; Graeber, Thomas G; Ribas, Antoni; McArthur, Grant A; Smyth, Mark J.

J Clin Invest ; 133(24)2023 12 15.

Article em En | MEDLINE | ID: mdl-38099495

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10721136
https://dx.doi.org/10.1172/JCI177489

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: J Clin Invest Ano de publicação: 2023 Tipo de documento: Article